2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Timothy Gilliam, B.S.

B.S.
University of North Carolina at Chapel Hill
101 Manning Dr.
Chapel Hill, NC
USA 27599

Papers:
147 The HMG-CoA reductase inhibitor, simvastatin, has anti-tumorigenic effects in ovarian cancer cell lines and a genetically engineered serous ovarian cancer mouse model.